0001947620-23-000001.txt : 20230427 0001947620-23-000001.hdr.sgml : 20230427 20230427125214 ACCESSION NUMBER: 0001947620-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230427 DATE AS OF CHANGE: 20230427 EFFECTIVENESS DATE: 20230427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lapix Therapeutics Inc. CENTRAL INDEX KEY: 0001947620 IRS NUMBER: 842410144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-480185 FILM NUMBER: 23854001 BUSINESS ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 1 (617) 766-3909 MAIL ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0001947620 Lapix Therapeutics Inc. 451 D Street Suite 707 BOSTON MA MASSACHUSETTS 02210 1 (617) 766-3909 DELAWARE Pstology Inc. None Corporation true 2019 Anas Fathallah c/o Lapix Therapeutics, Inc. 451 D Street, Suite 707 Boston MA MASSACHUSETTS 02210 Executive Officer Director Jason Norris c/o Lapix Therapeutics, Inc. 451 D Street, Suite 707 Boston MA MASSACHUSETTS 02210 Director Biotechnology Decline to Disclose 06b false 2023-04-14 false true false 0 14557480 5947478 8610002 Includes conversion of outstanding indebtedness. false 32 0 0 0 true false Lapix Therapeutics Inc. Anas Fathallah Anas Fathallah President 2023-04-27